aluates Reports

$ 0.0

Automative

Global Angiotensin II Receptor Blocker (ARBs) API Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-16X4834

Global Angiotensin II Receptor Blocker ARBs API Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Angiotensin II Receptor Blocker (ARBs) API Market Research Report 2024

Code: QYRE-Auto-16X4834

Report

June 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Teva Pharmaceutical

Aurobindo Pharma

Viatris

Tianyu Pharma

Huahai Pharmaceutical

Menovo

Rundu Pharma

Kinglyuan Pharmaceutical

Second Pharma

Apeloa

Jiangxi Synergy Pharmaceutical

Angiotensin II Receptor Blocker (ARBs) API Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Angiotensin II Receptor Blocker (ARBs) API Market

Valsartan, losartan, irbesartan and other “-sartan” drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.

The global Angiotensin II Receptor Blocker (ARBs) API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blocker (ARBs) API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blocker (ARBs) API.

Report Scope

The Angiotensin II Receptor Blocker (ARBs) API market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin II Receptor Blocker (ARBs) API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Angiotensin II Receptor Blocker (ARBs) API companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Angiotensin II Receptor Blocker (ARBs) API Market Report

Report Metric	Details
Report Name	Angiotensin II Receptor Blocker (ARBs) API Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Valsartan Irbesartan Telmisartan Losartan Candesartan Olmesartan Others
Segment by Application	Essential Hypertension Secondary Hypertension
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva Pharmaceutical, Aurobindo Pharma, Viatris, Tianyu Pharma, Huahai Pharmaceutical, Menovo, Rundu Pharma, Kinglyuan Pharmaceutical, Second Pharma, Apeloa, Jiangxi Synergy Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiotensin II Receptor Blocker (ARBs) API companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The main players in the Angiotensin II Receptor Blocker (ARBs) API Market are Teva Pharmaceutical, Aurobindo Pharma, Viatris, Tianyu Pharma, Huahai Pharmaceutical, Menovo, Rundu Pharma, Kinglyuan Pharmaceutical, Second Pharma, Apeloa, Jiangxi Synergy Pharmaceutical

What are the Application segmentation covered in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The Applications covered in the Angiotensin II Receptor Blocker (ARBs) API Market report are Essential Hypertension, Secondary Hypertension

What are the Type segmentation covered in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The Types covered in the Angiotensin II Receptor Blocker (ARBs) API Market report are Valsartan, Irbesartan, Telmisartan, Losartan, Candesartan, Olmesartan, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Valsartan

1.2.3 Irbesartan

1.2.4 Telmisartan

1.2.5 Losartan

1.2.6 Candesartan

1.2.7 Olmesartan

1.2.8 Others

1.3 Market by Application

1.3.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Essential Hypertension

1.3.3 Secondary Hypertension

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Perspective (2019-2030)

2.2 Angiotensin II Receptor Blocker (ARBs) API Growth Trends by Region

2.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Region (2019-2024)

2.2.3 Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2025-2030)

2.3 Angiotensin II Receptor Blocker (ARBs) API Market Dynamics

2.3.1 Angiotensin II Receptor Blocker (ARBs) API Industry Trends

2.3.2 Angiotensin II Receptor Blocker (ARBs) API Market Drivers

2.3.3 Angiotensin II Receptor Blocker (ARBs) API Market Challenges

2.3.4 Angiotensin II Receptor Blocker (ARBs) API Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue

3.1.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue (2019-2024)

3.1.2 Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Players (2019-2024)

3.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Angiotensin II Receptor Blocker (ARBs) API Revenue

3.4 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio

3.4.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2023

3.5 Angiotensin II Receptor Blocker (ARBs) API Key Players Head office and Area Served

3.6 Key Players Angiotensin II Receptor Blocker (ARBs) API Product Solution and Service

3.7 Date of Enter into Angiotensin II Receptor Blocker (ARBs) API Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Type

4.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Type (2019-2024)

4.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2025-2030)

5 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Application

5.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Application (2019-2024)

5.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Angiotensin II Receptor Blocker (ARBs) API Market Size (2019-2030)

6.2 North America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024)

6.4 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size (2019-2030)

7.2 Europe Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024)

7.4 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size (2019-2030)

8.2 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2019-2024)

8.4 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size (2019-2030)

9.2 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024)

9.4 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size (2019-2030)

10.2 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024)

10.4 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva Pharmaceutical

11.1.1 Teva Pharmaceutical Company Detail

11.1.2 Teva Pharmaceutical Business Overview

11.1.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction

11.1.4 Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.1.5 Teva Pharmaceutical Recent Development

11.2 Aurobindo Pharma

11.2.1 Aurobindo Pharma Company Detail

11.2.2 Aurobindo Pharma Business Overview

11.2.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction

11.2.4 Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.2.5 Aurobindo Pharma Recent Development

11.3 Viatris

11.3.1 Viatris Company Detail

11.3.2 Viatris Business Overview

11.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Introduction

11.3.4 Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.3.5 Viatris Recent Development

11.4 Tianyu Pharma

11.4.1 Tianyu Pharma Company Detail

11.4.2 Tianyu Pharma Business Overview

11.4.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction

11.4.4 Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.4.5 Tianyu Pharma Recent Development

11.5 Huahai Pharmaceutical

11.5.1 Huahai Pharmaceutical Company Detail

11.5.2 Huahai Pharmaceutical Business Overview

11.5.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction

11.5.4 Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.5.5 Huahai Pharmaceutical Recent Development

11.6 Menovo

11.6.1 Menovo Company Detail

11.6.2 Menovo Business Overview

11.6.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Introduction

11.6.4 Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.6.5 Menovo Recent Development

11.7 Rundu Pharma

11.7.1 Rundu Pharma Company Detail

11.7.2 Rundu Pharma Business Overview

11.7.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction

11.7.4 Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.7.5 Rundu Pharma Recent Development

11.8 Kinglyuan Pharmaceutical

11.8.1 Kinglyuan Pharmaceutical Company Detail

11.8.2 Kinglyuan Pharmaceutical Business Overview

11.8.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction

11.8.4 Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.8.5 Kinglyuan Pharmaceutical Recent Development

11.9 Second Pharma

11.9.1 Second Pharma Company Detail

11.9.2 Second Pharma Business Overview

11.9.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction

11.9.4 Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.9.5 Second Pharma Recent Development

11.10 Apeloa

11.10.1 Apeloa Company Detail

11.10.2 Apeloa Business Overview

11.10.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Introduction

11.10.4 Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.10.5 Apeloa Recent Development

11.11 Jiangxi Synergy Pharmaceutical

11.11.1 Jiangxi Synergy Pharmaceutical Company Detail

11.11.2 Jiangxi Synergy Pharmaceutical Business Overview

11.11.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction

11.11.4 Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

11.11.5 Jiangxi Synergy Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Teva Pharmaceutical

Aurobindo Pharma

Viatris

Tianyu Pharma

Huahai Pharmaceutical

Menovo

Rundu Pharma

Kinglyuan Pharmaceutical

Second Pharma

Apeloa

Jiangxi Synergy Pharmaceutical

List of Tables

Table 1. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Valsartan

Table 3. Key Players of Irbesartan

Table 4. Key Players of Telmisartan

Table 5. Key Players of Losartan

Table 6. Key Players of Candesartan

Table 7. Key Players of Olmesartan

Table 8. Key Players of Others

Table 9. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2019-2024)

Table 13. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2025-2030)

Table 15. Angiotensin II Receptor Blocker (ARBs) API Market Trends

Table 16. Angiotensin II Receptor Blocker (ARBs) API Market Drivers

Table 17. Angiotensin II Receptor Blocker (ARBs) API Market Challenges

Table 18. Angiotensin II Receptor Blocker (ARBs) API Market Restraints

Table 19. Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players (2019-2024)

Table 21. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2023)

Table 22. Ranking of Global Top Angiotensin II Receptor Blocker (ARBs) API Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Angiotensin II Receptor Blocker (ARBs) API Product Solution and Service

Table 26. Date of Enter into Angiotensin II Receptor Blocker (ARBs) API Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2019-2024)

Table 30. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2025-2030)

Table 32. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2019-2024)

Table 34. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2025-2030)

Table 36. North America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2025-2030) & (US$ Million)

Table 51. Teva Pharmaceutical Company Detail

Table 52. Teva Pharmaceutical Business Overview

Table 53. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product

Table 54. Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 55. Teva Pharmaceutical Recent Development

Table 56. Aurobindo Pharma Company Detail

Table 57. Aurobindo Pharma Business Overview

Table 58. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product

Table 59. Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 60. Aurobindo Pharma Recent Development

Table 61. Viatris Company Detail

Table 62. Viatris Business Overview

Table 63. Viatris Angiotensin II Receptor Blocker (ARBs) API Product

Table 64. Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 65. Viatris Recent Development

Table 66. Tianyu Pharma Company Detail

Table 67. Tianyu Pharma Business Overview

Table 68. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product

Table 69. Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 70. Tianyu Pharma Recent Development

Table 71. Huahai Pharmaceutical Company Detail

Table 72. Huahai Pharmaceutical Business Overview

Table 73. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product

Table 74. Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 75. Huahai Pharmaceutical Recent Development

Table 76. Menovo Company Detail

Table 77. Menovo Business Overview

Table 78. Menovo Angiotensin II Receptor Blocker (ARBs) API Product

Table 79. Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 80. Menovo Recent Development

Table 81. Rundu Pharma Company Detail

Table 82. Rundu Pharma Business Overview

Table 83. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product

Table 84. Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 85. Rundu Pharma Recent Development

Table 86. Kinglyuan Pharmaceutical Company Detail

Table 87. Kinglyuan Pharmaceutical Business Overview

Table 88. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product

Table 89. Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 90. Kinglyuan Pharmaceutical Recent Development

Table 91. Second Pharma Company Detail

Table 92. Second Pharma Business Overview

Table 93. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product

Table 94. Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 95. Second Pharma Recent Development

Table 96. Apeloa Company Detail

Table 97. Apeloa Business Overview

Table 98. Apeloa Angiotensin II Receptor Blocker (ARBs) API Product

Table 99. Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 100. Apeloa Recent Development

Table 101. Jiangxi Synergy Pharmaceutical Company Detail

Table 102. Jiangxi Synergy Pharmaceutical Business Overview

Table 103. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product

Table 104. Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024) & (US$ Million)

Table 105. Jiangxi Synergy Pharmaceutical Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Type: 2023 VS 2030

Figure 3. Valsartan Features

Figure 4. Irbesartan Features

Figure 5. Telmisartan Features

Figure 6. Losartan Features

Figure 7. Candesartan Features

Figure 8. Olmesartan Features

Figure 9. Others Features

Figure 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Application: 2023 VS 2030

Figure 12. Essential Hypertension Case Studies

Figure 13. Secondary Hypertension Case Studies

Figure 14. Angiotensin II Receptor Blocker (ARBs) API Report Years Considered

Figure 15. Global Angiotensin II Receptor Blocker (ARBs) API Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Angiotensin II Receptor Blocker (ARBs) API Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region: 2023 VS 2030

Figure 18. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players in 2023

Figure 19. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2023

Figure 21. North America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2019-2030)

Figure 23. United States Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2019-2030)

Figure 27. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2019-2030)

Figure 35. China Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2019-2030)

Figure 43. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2019-2030)

Figure 47. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Teva Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 50. Aurobindo Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 51. Viatris Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 52. Tianyu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 53. Huahai Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 54. Menovo Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 55. Rundu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 56. Kinglyuan Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 57. Second Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 58. Apeloa Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 59. Jiangxi Synergy Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions